Tablet / Weight Loss & GLP-1
BPC-157 Oral
Body Protection Compound · 500mcg
$79 USD per unit · Coming soon · 30 capsules
Oral BPC-157 supporting GI mucosal health during GLP-1 protocols. Protects gut integrity and enhances metabolic peptide tolerance.
Product information
BPC-157 is a pentadecapeptide originally isolated from human gastric juice. In the context of GLP-1 therapy, oral BPC-157 supports gastrointestinal mucosal integrity, addressing the GI side effects commonly associated with semaglutide and tirzepatide protocols.
Our oral formulation delivers 500mcg per capsule in a bioavailable matrix designed for gut-brain axis support.
Benefits
- GI mucosal protection
- GLP-1 protocol tolerance support
- Gut-brain axis signaling
- Tissue repair acceleration
Specifications
- Fill / pack
- 30 capsules
- Format
- Tablet
- Serving
- 500mcg
- Servings per container
- 30 per bottle
- Listed purity
- 99.72%
- Molecular weight / composition
- 1419.53 Da
- Storage
- Refrigerate after opening
Frequently asked questions
How should I store this product?
Refrigerate at 2-8°C. Keep away from direct light. Once reconstituted, use within 30 days.
How long until I see results?
Most users report initial effects within 2-4 weeks, with optimal results typically observed after 8-12 weeks of consistent use. Individual responses vary.
Is a Certificate of Analysis included?
Yes. Every order includes a batch-specific COA with HPLC purity analysis, amino acid sequence verification, and endotoxin testing results.
Should I take this with food?
Can be taken with or without food. Some users prefer taking on an empty stomach for optimal absorption.
Dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Browse all peptide bioregulators or the Weight Loss & GLP-1 collection. All formulations.